Charles Schwab’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.28M Sell
533,394
-17,538
-3% -$168K ﹤0.01% 2468
2025
Q4
$6.42M Buy
550,932
+30,174
+6% +$293K ﹤0.01% 2336
2025
Q3
$5.23M Buy
520,758
+78,556
+18% +$1.13M ﹤0.01% 2422
2025
Q2
$7.72M Buy
442,202
+25,545
+6% +$369K ﹤0.01% 2138
2025
Q1
$5.24M Sell
416,657
-10,820
-3% -$130K ﹤0.01% 2254
2024
Q4
$4.51M Buy
427,477
+3,530
+0.8% +$49.4K ﹤0.01% 2373
2024
Q3
$6.15M Buy
423,947
+8,417
+2% +$100K ﹤0.01% 2269
2024
Q2
$3.54M Buy
415,530
+70,235
+20% +$623K ﹤0.01% 2511
2024
Q1
$3.53M Buy
345,295
+15,745
+5% +$117K ﹤0.01% 2416
2023
Q4
$1.81M Buy
329,550
+5,147
+2% +$22.6K ﹤0.01% 2651
2023
Q3
$1.23M Buy
324,403
+252,792
+353% +$1.66M ﹤0.01% 2736
2023
Q2
$480K Buy
71,611
+55,441
+343% +$370K ﹤0.01% 3075
2023
Q1
$105K Hold
16,170
﹤0.01% 3242
2022
Q4
$138K Buy
+16,170
New +$105K ﹤0.01% 3230
2022
Q3
Sell
-106,414
Closed -$452K 3547
2022
Q2
$452K Sell
106,414
-40,961
-28% -$143K ﹤0.01% 3110
2022
Q1
$518K Sell
147,375
-1,568
-1% -$6.83K ﹤0.01% 3092
2021
Q4
$992K Buy
148,943
+9,838
+7% +$79.9K ﹤0.01% 2914
2021
Q3
$1.39M Buy
139,105
+53,301
+62% +$1.31M ﹤0.01% 2774
2021
Q2
$2.65M Buy
85,804
+1,391
+2% +$44.6K ﹤0.01% 2618
2021
Q1
$3.68M Buy
+84,413
New +$3.99M ﹤0.01% 2442

Other funds holding SPRY